cephalosporin c has been researched along with s 1006 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, NX; Fang, W; Gu, JW; Neu, HC | 1 |
| Konishi, M; Shimizu, K; Totsuka, K; Yamamoto, S | 1 |
| Matsuno, S; Mizojiri, K; Nakashima, M; Oguma, T; Uematsu, T; Yamamoto, S; Yoshida, T | 1 |
| Aoki, S; Nishimura, T; Sugita, K; Takagi, M | 1 |
| Ishihara, T; Nakamura, H; Sano, T; Tezuka, T; Toyonaga, Y | 1 |
1 trial(s) available for cephalosporin c and s 1006
| Article | Year |
|---|---|
Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
Topics: Adult; Carnitine; Cephalosporins; Drug Administration Schedule; Drug Evaluation; Humans; Male; Pentanoic Acids; Tablets | 1992 |
4 other study(ies) available for cephalosporin c and s 1006
| Article | Year |
|---|---|
In vitro activity and susceptibility to hydrolysis of S-1006.
Topics: Bacteria; beta-Lactamases; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1992 |
Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Carnitine; Cephalosporins; Humans; Male; Pentanoic Acids | 1992 |
[Clinical evaluation of S-1108 in pediatric field].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Creatine Kinase; Drug Evaluation; Eosinophilia; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1993 |
[Pharmacokinetic and clinical studies of S-1108 in the pediatric field].
Topics: Absorption; Bacteria; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1993 |